I really pray that you are correct, as my most significant concern (assuming we get approval) is our ability to mass produce.

We are still very early on in this pandemic, and are still learning about it as well as how Leronlimab will fare. Not to mention whether or not Leronlimab could potentially make the leap from treatment, to prophylaxis.

If, and this is a MONSTER if, Leronlimab does prove to be a prophylaxis, we are going to need to scale manufacturing considerably.